Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-6557 |13|4|325-333

ISSN： 1573-403x

Source： Current Cardiology Reviews, Vol.13, Iss.4, 2017-10, pp. : 325-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial

By  

Clinical Cardiology, Vol. 39, Iss. 9, 2016-09 ,pp. : 497-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 192-202

Bentham Science Publishers

Access to resources Recommend Favorite

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 11, 2015-11 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 14-20

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antiplatelet Therapy in Acute Coronary Syndromes: What is New in the Pipeline?

By  

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 606-618

Bentham Science Publishers

Access to resources Recommend Favorite